Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mirati Therapeutics (NQ: MRTX )

68.16 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 68.16
Bid (Size) 25.00 (1)
Ask (Size) 104.00 (1)
Prev. Close 68.16
Today's Range 68.16 - 68.16
52wk Range 32.96 - 195.99
Shares Outstanding 51,623,193
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma. 
Via Talk Markets
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, investor! We're back with a breakdown of the biggest pre-market stock movers for Tuesday to get the day started! 
Via InvestorPlace

Performance

YTD
-54.85%
-54.85%
1 Month
+71.21%
+71.21%
3 Month
-14.53%
-14.53%
6 Month
-53.83%
-53.83%
1 Year
-60.43%
-60.43%

More News

Read More
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Mirati Therapeutics, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Mirati Therapeutics Posts Adagrasib Data In Lung Cancer Patients With CNS Metastases
Via Benzinga
Expert Ratings for Mirati Therapeutics
Via Benzinga
Here's What Cramer Has To Say About Zuora, Johnson Controls International And More
Via Benzinga
79 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Rises 100 Points; Kiromic BioPharma Shares Spike Higher
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Mid-Day Market Update: Nasdaq Turns Higher; REV Group Shares Plunge
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
The Surprising Way Mirati Therapeutics Is Angling To Rival Amgen — And Could Succeed
Via Investor's Business Daily
Mid-Morning Market Update: Markets Open Lower; United Natural Foods Tops Q3 Views
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2022
Via Benzinga
69 Biggest Movers From Friday
Via Benzinga
Stocks Pacing for Weekly Losses Despite Strong Jobs Data
Via Talk Markets
40 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
70 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Mirati Therapeutics Plunges As Its Hopes To Take On Amgen In Lung Cancer Crash
Via Investor's Business Daily
Mid-Morning Market Update: Markets Open Higher; US Goods Trade Deficit Narrows In April
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.